Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,079 | 6,382 | 6,396 | 6,697 | 14,925 |
| Marketable Securities | 1,499 | 15,047 | 20,631 | 27,558 | 25,380 |
| TOTAL | $15,447 | $23,257 | $28,504 | $36,059 | $42,492 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 154 | 602 | 637 | 670 | 703 |
| TOTAL | $154 | $602 | $637 | $670 | $703 |
| Total Assets | $15,601 | $23,859 | $29,141 | $36,729 | $43,195 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,198 | 1,903 | 1,462 | 1,148 | 2,133 |
| Accrued Expenses | 5,064 | 5,967 | 4,475 | 3,877 | 2,868 |
| TOTAL | $6,453 | $8,055 | $6,116 | $5,198 | $5,152 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 50 | 99 | 145 | 191 |
| TOTAL | $N/A | $50 | $99 | $1,479 | $1,047 |
| Total Liabilities | $6,453 | $8,105 | $6,215 | $6,677 | $6,199 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,960 | 2,960 | 2,960 | 2,960 | 2,948 |
| Common Shares | 3 | 3 | 3 | 3 | 59 |
| Retained earnings | -223,190 | -214,726 | -206,167 | -197,779 | -188,615 |
| Other shareholders' equity | 1 | -3 | -8 | 3 | 0 |
| TOTAL | $9,148 | $15,754 | $22,926 | $30,052 | $36,996 |
| Total Liabilities And Equity | $15,601 | $23,859 | $29,141 | $36,729 | $43,195 |